Narmada Gelatines Ltd

Narmada Gelatines Ltd

₹ 479 -2.69%
08 Jun - close price
About

Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]

Key Points

Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water

  • Market Cap 290 Cr.
  • Current Price 479
  • High / Low 530 / 327
  • Stock P/E 10.2
  • Book Value 234
  • Dividend Yield 2.09 %
  • ROCE 27.9 %
  • ROE 21.8 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 38.6% CAGR over last 5 years

Cons

  • The company has delivered a poor sales growth of 9.82% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
49.86 43.66 41.59 47.08 49.47 43.22 47.91 48.02 49.77 45.77 51.21 56.73 61.70
43.18 37.57 37.71 42.38 42.85 37.93 42.68 41.44 42.29 38.25 41.86 46.06 47.94
Operating Profit 6.68 6.09 3.88 4.70 6.62 5.29 5.23 6.58 7.48 7.52 9.35 10.67 13.76
OPM % 13.40% 13.95% 9.33% 9.98% 13.38% 12.24% 10.92% 13.70% 15.03% 16.43% 18.26% 18.81% 22.30%
0.19 0.27 0.39 0.45 0.50 0.56 0.77 0.29 0.03 0.04 0.55 0.05 0.14
Interest 0.11 0.09 0.09 0.05 0.03 0.03 0.27 0.55 0.36 0.24 0.20 0.29 0.29
Depreciation 0.48 0.50 0.51 0.51 0.52 0.52 0.59 0.56 0.55 0.65 0.65 0.65 0.92
Profit before tax 6.28 5.77 3.67 4.59 6.57 5.30 5.14 5.76 6.60 6.67 9.05 9.78 12.69
Tax % 26.43% 24.78% 27.25% 25.49% 25.27% 24.53% 25.49% 25.69% 18.79% 25.34% 28.40% 24.34% 24.51%
4.62 4.34 2.67 3.42 4.91 4.00 3.83 4.28 5.36 4.98 6.48 7.40 9.58
EPS in Rs 7.64 7.17 4.41 5.65 8.12 6.61 6.33 7.07 8.86 8.23 10.71 12.23 15.84
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
134 131 113 118 126 134 135 157 191 182 189 215
113 120 109 112 116 120 127 143 171 161 164 174
Operating Profit 21 11 4 5 9 14 8 15 20 21 25 41
OPM % 16% 8% 3% 5% 7% 11% 6% 9% 10% 12% 13% 19%
4 3 6 4 5 6 6 3 2 2 2 1
Interest 0 0 0 0 0 0 0 0 0 0 1 1
Depreciation 1 1 1 1 1 1 1 2 2 2 2 3
Profit before tax 23 13 8 8 13 18 11 15 20 21 23 38
Tax % 34% 36% 27% 5% 24% 28% 26% 20% 23% 26% 24% 26%
16 8 6 8 10 13 8 12 15 15 17 28
EPS in Rs 25.62 13.70 10.10 13.29 16.63 21.29 13.98 20.40 25.26 25.34 28.45 47.01
Dividend Payout % 14% 29% 40% 30% 60% 47% 72% 49% 396% 39% 35% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: 10%
3 Years: 4%
TTM: 14%
Compounded Profit Growth
10 Years: 14%
5 Years: 39%
3 Years: 26%
TTM: 69%
Stock Price CAGR
10 Years: 14%
5 Years: 22%
3 Years: 15%
1 Year: 20%
Return on Equity
10 Years: 9%
5 Years: 14%
3 Years: 17%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 98 103 112 118 125 130 133 139 88 103 113 135
1 2 0 0 2 0 0 0 0 0 13 8
15 17 21 16 22 24 26 25 23 25 27 26
Total Liabilities 120 128 140 140 155 161 165 170 117 134 159 175
23 23 22 25 24 26 29 27 28 27 33 41
CWIP 0 0 0 0 1 2 0 0 0 0 7 5
Investments 27 34 45 53 68 65 50 48 4 10 41 41
70 72 73 62 61 69 85 94 85 97 78 87
Total Assets 120 128 140 140 155 161 165 170 117 134 159 175

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
6 7 7 9 12 5 3 2 14 15 17 25
-0 -7 -2 -2 -5 -4 6 10 44 -12 -29 -13
-3 -2 -5 -3 -1 -9 -7 -6 -67 -0 5 -12
Net Cash Flow 3 -2 0 4 6 -8 2 6 -9 2 -6 -0
Free Cash Flow 6 6 7 4 11 1 -0 2 12 13 2 15
CFO/OP 66% 99% 246% 208% 152% 58% 96% 42% 101% 90% 92% 79%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 41 47 52 59 56 55 48 36 37 44 48 49
Inventory Days 194 169 192 144 144 166 166 185 152 161 155 156
Days Payable 21 23 52 40 62 63 62 57 42 50 57 39
Cash Conversion Cycle 214 193 193 163 138 158 152 164 147 155 146 166
Working Capital Days 117 120 146 127 95 108 115 119 97 103 88 104
ROCE % 21% 12% 4% 5% 7% 11% 5% 10% 16% 20% 20% 28%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees
Count

Log in to view insights

Please log in to see hidden values.

Login
Installed Capacity - Gelatine
MT per annum
Sales Volume - Di-calcium Phosphate (DCP)
MT
Sales Volume - Gelatine
MT
Installed Capacity - Di-calcium Phosphate (DCP)
MT per annum
Production Volume - Di-calcium Phosphate (DCP)
MT
Production Volume - Gelatine
MT
Production Volume - Ossein
MT
Installed Capacity - Ossein
MT per annum
Capacity Utilization - Gelatine
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
75.00% 77.65% 77.65% 77.65% 77.65% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
24.99% 22.35% 22.34% 22.34% 22.34% 24.99% 24.99% 25.00% 25.00% 24.99% 24.99% 25.00%
No. of Shareholders 7,6787,5527,5697,5157,3787,8647,5477,5607,6157,8097,5597,312

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents